Baker McKenzie Advises RaySearch Laboratories in Sell-down of Shares

The founder and CEO of RaySearch Laboratories, Johan Löf, has successfully completed the sale of 2,000,000 class B shares in RaySearch Laboratories AB corresponding to 5.8 per cent of the share capital of the company. The sale was carried out through a book building procedure and generated proceeds of 500 msek. 

Following the sell-down, Johan Löf holds 3,443,084 class A shares and 68,393 class B shares in the company, corresponding to approximately 40.5 per cent of the total number of voting rights and 10.2 per cent of the share capital of the company.

RaySearch Laboratories is active in the medical technology industry and focuses on the development and manufacture of software for radiation therapy of cancer. The company's products are aimed at healthcare institutions and oncologists. Operations are global with a primary presence in Europe, North America and Asia. RaySearch Laboratories was founded in 2000 and is headquartered in Stockholm, Sweden.

SEB acted as Sole Global Coordinator and Bookrunner and Baker McKenzie acted as legal advisor to the seller with an international capital markets team consisting of Joakim Falkner and Monica Ericson in Stockholm as well as Adam Farlow and Charles Farnsworth in London.